Beginners typically start with 0.5-1mg administered subcutaneously 3-5 times per week
For all purchases before 2015, no changes were made regarding product availability or specifications as used by Purchasing teams under Hospira
Studies conducted to date have demonstrated DSIP has potential in this area, namely by protecting neurons from that type of damage by boosting antioxidant production in the brain
For patients buying topical GHK-Cu products from the cosmetic and skincare market: this regulatory action does not touch the cosmetic GHK-Cu category, which has always been regulated separately under FDA's cosmetic rather than drug authorities
US 8598118, Harding JW, Wright JW, Benoist CC, Kawas LH, Wayman GA, "Hepatocyte growth factor mimics as therapeutic agents", issued 3 December 2013 "Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs"
Hypertension (2020) 76:83948